Contact us
Expertise in real world data
Late phase CRO: Oxon Epidemiology
Real world
data solutions
European CRO
with pan-European, Asian
and Latin American reach
Late phase CRO: Oxon Epidemiology
Epidemiology
Clinical, PRO
pharmacoeconomic,
methodological, statistical
and operational expertise for
field and database studies
Late phase CRO: Oxon Epidemiology
Product Safety
Quantitative safety
with clinical insight,
quality and compliance
Late phase CRO: Oxon Epidemiology
Outcomes
Extending health economics
and patient–reported outcomes
in observational studies
Late phase CRO: Oxon Epidemiology
Data integration
Systematic review
Meta-analysis
Benefit-risk analysis
Late phase CRO: Oxon Epidemiology
Consulting
Evidence strategy
Decision analysis & Modelling
Data sources
Welcome to OXON Epidemiology
Dr Nawab Qizilbash will participate in EMA/DIA Information Day on Measuring the Impact on Pharmacovigilance Activities
EMA | 14 November 2017 8:00-16:45 (UK TIME)
OXON presenting and Exhibiting at the 20th ISPOR Annual European Congress
from 4-8 November 2017 in Glasgow, Scotland
OXON is a London/Madrid-based full service scientific CRO that specialises in real world data to support pre-approval and late phase biopharmaceutical and medical device products
We conduct PAN-EUROPEAN & GLOBAL SAFETY & OUTCOMES OBSERVATIONAL STUDIES
  • Field studies via a 7-year alliance with the 10th largest global CRO for local country operations
  • Database studies via links with leading pharmacoepidemiologists
  • Hybrid studies
  • Data integration
OXON IS A PREFERRED SUPPLIER TO BIG PHARMA FOR OBSERVATIONAL STUDIES
LINKS WITH REGULATORS: Joint Coordinator of the ENCePP Special Interest Group on Impact of PV Activities at EMA
We conduct WORLD CLASS SCIENCE
  • Academic link with the London School of Hygiene & Tropical Medicine
  • Leading academic methodological and clinical consultants: e.g. eminent medical statistician, Professor Stuart Pocock
  • Publications by OXON staff include Lancet (x7), JAMA (x1), BMJ (x4)
For People involved in observational studies:
Epidemiologists, Drug Safety specialists, Scientific Leads, Medical Affairs and others



Click to read more
OXON initiatives and activities at the European Medicines Agency






Click to read more
Access to OXON’s open and closed projects by study investigators, collaborating physicians and patients & relatives



Click to read more
Network of alliances and academic & clinical consultants






Click to read more
Courses and Resources
Courses
and Resources
Late phase CRO: Oxon Epidemiology
OXON
Activities
Access for Investigators and Patients
Access for Investigators
and Patients
WorldWide Network
WorldWide
Network
Copyright © 2013 Oxon All Rights Reserved - Late phase CRO
logo oxon
Copyright © 2013.
All Rights Reserved - Late Phase CRO
Web development: Cerotec Estudios
Site Menu
What we do
Prospective observational studies and registries, retrospective chart review cohort and cross-sectional studies, cross-sectional surveys, database studies, hybrid field and database studies, risk minimisation , Risk management plans, pragmatic trials, data aggregation and integration, Meta-analysis, H-E / Q.O.L. within observational studies, Consulting, , Validated eDC and e-Technologies,.
Contact
Oxon Epidemiology S.L.
The Euston Office
1 Euston Square
40 Melton Street
London NW1 2FD
Tlf: +44(0) 203 574 4965
Fax: +44(0) 203 397 7497
E-mail:
Legal terms and conditions
Privacy policy